Targa Resources Corp. Reports Record Second Quarter 2024 Results and Increases Full Year 2024 Outlook
Newsfilter· 2024-08-01 18:00
HOUSTON, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE: TRGP) ("TRGP," the "Company" or "Targa") today reported second quarter 2024 results. Second quarter 2024 net income attributable to Targa Resources Corp. was $298.5 million compared to $329.3 million for the second quarter of 2023. The Company reported adjusted earnings before interest, income taxes, depreciation and amortization, and other non-cash items ("adjusted EBITDA")(1) of $984.3 million for the second quarter of 2024 compared t ...
Bilibili Inc. to Report Second Quarter 2024 Financial Results on Thursday, August 22, 2024
Newsfilter· 2024-08-01 18:00
文章核心观点 - 公司将于2024年8月22日发布2024年第二季度未经审计的财务业绩 [1] - 公司将于2024年8月22日上午8点(美东时间)举行财报电话会议 [2] - 公司是中国年轻一代的标志性品牌和领先视频社区,致力于丰富年轻人的日常生活 [5] - 公司提供多样化的视频内容,并以"你喜欢的所有视频"为价值主张 [5] - 公司以热情用户、优质内容、才华横溢的创作者以及他们之间的强烈情感纽带为基础建立社区 [5] 公司信息 - 公司在纳斯达克和香港交易所上市 [1] - 公司总部位于中国上海 [1] - 公司为投资者和媒体提供了多种联系方式 [5][6]
Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody
Newsfilter· 2024-08-01 18:00
DALLAS and SHANGHAI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil") and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, "ImmuneOnco"), today announced a definitive agreement pursuant to which Instil is in-licensing ex-China development and commercial rights to ImmueOnco's proprietary PD-L1xVEGF bispecific antibody, IMM2510, as well as its next-generation anti-CTLA-4 antibody, IMM27M. IMM2510 is a novel, potentially best-in-class bispecific antibody consisting o ...
Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain
Newsfilter· 2024-08-01 18:00
STAFFORD, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the following update of the expansion of clinical sites into Spain. As previously announced, the Company has partnered with GEICAM, the largest academic breast cancer research network in Spain, where 38 ...
Realtor.com® July Housing Report: Inventory Hits Post-Pandemic High
Prnewswire· 2024-08-01 18:00
Seattle (37.3%), San Jose (30.8%) and Columbus (17.4%) See Highest Gains in New Listings this July SANTA CLARA, Calif., Aug. 1, 2024 /PRNewswire/ -- According to the Realtor.com® July housing data, the market is becoming more buyer friendly through a combination of rising inventory levels and price cut reductions. Homes actively for sale grew 36.6% in July 2024 relative to the same time last year, hitting a post-pandemic high, while the share of listings with price cuts reached 18.9%, the highest rate sinc ...
Digihost Announces Cash and Crypto Position and Provides July 2024 Production Update
Newsfilter· 2024-08-01 18:00
HOUSTON, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Digihost Technology Inc. ("Digihost" or the "Company") (Nasdaq / TSXV: DGHI), an innovative U.S. based blockchain technology and computer infrastructure company, is pleased to provide unaudited comparative Bitcoin ("BTC") production results for the month ended July 31, 2024, combined with an operations update. All monetary references are expressed in USD unless otherwise indicated. Monthly Production Highlights for July 2024 The Company held cash, BTC and cash depo ...
DFIN Client Successfully Live-Files New Tailored Shareholder Reports with SEC through ArcReporting
Prnewswire· 2024-08-01 18:00
DFIN's ArcReporting® Streamlines Preparation, iXBRL Tagging, and Filing Process for Large Asset Management CompanyCHICAGO, Aug. 1, 2024 /PRNewswire/ -- DFIN (NYSE: DFIN), a leading risk and compliance company, today announced that a large Los Angeles-based asset manager used its proprietary SaaS solution, ArcReporting®, to successfully create, iXBRL-tag, and live-file a Tailored Shareholder Report (TSR) on Form N-CSR in compliance with the SEC's new TSR rule.The SEC adopted the TSR rule to simplify and stan ...
Air Products Reports Fiscal 2024 Third Quarter GAAP EPS of $3.13 and Adjusted EPS of $3.20
Prnewswire· 2024-08-01 18:00
Q3 FY24 (comparisons versus prior year):GAAP EPS# of $3.13, up 17 percent; GAAP net income of $709 million, up 16 percent; and GAAP net income margin of 23.7 percent, up 360 basis pointsAdjusted EPS* of $3.20, up seven percent; adjusted EBITDA* of $1.3 billion, up five percent; and adjusted EBITDA margin* of 42.4 percent, up 260 basis pointsRecent HighlightsClean hydrogen / energy transitionSigned a 15-year agreement to supply 70,000 tons of green hydrogen annually starting in 2030, helping to decarbonize T ...
Shawbrook to Leverage nCino to Automate Complex Lending Processes and Optimise Client Portfolios to Achieve Faster Time to Market
Newsfilter· 2024-08-01 14:30
LONDON, Aug. 01, 2024 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ:NCNO), a pioneer in cloud banking for the global financial services industry, today announced that Shawbrook has chosen nCino to help automate its loan origination processes, while expanding portfolio management capabilities through nCino's cloud-based platform. With nCino's intelligent solutions, Shawbrook's team will be able to more efficiently complete routine tasks, allowing for more focus on delivering impactful services to the SME market it ...
VEON Announces Intention to Delist from Euronext Amsterdam and to Initiate a Share Buyback Program for up to USD 100 million
Newsfilter· 2024-08-01 14:30
文章核心观点 - 公司计划自愿从阿姆斯特丹Euronext证券交易所退市,将只在纳斯达克证券交易所上市[1][2] - 退市将简化公司的报告要求,有利于公司和投资者[2][3] - 退市后公司将启动最高1亿美元的股票回购计划,认为目前股价未能充分反映公司的价值[4][5] 公司概况 - 公司是一家全球性的数字运营商,提供融合连接和在线服务,拥有近1.6亿客户[6] - 公司总部位于阿姆斯特丹,在6个国家运营,占全球人口7%以上[6] - 公司致力于通过技术驱动的服务来改善人们的生活,推动经济增长[6]